![Sheldon Garrison](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sheldon Garrison
Nessuna posizione attualmente
Profilo
Sheldon Garrison worked as a Director for Pediatric & Rare Diseases at Promentis Pharmaceuticals, Inc. and as a Marketing Specialist at DNASTAR, Inc. He obtained an undergraduate and doctorate degree from the University of Wisconsin.
Precedenti posizioni note di Sheldon Garrison
Società | Posizione | Fine |
---|---|---|
DNASTAR, Inc.
![]() DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Corporate Officer/Principal | - |
Promentis Pharmaceuticals, Inc.
![]() Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI. | Corporate Officer/Principal | - |
Formazione di Sheldon Garrison
University of Wisconsin | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 2 |
---|---|
Promentis Pharmaceuticals, Inc.
![]() Promentis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Promentis Pharmaceuticals, Inc. engages in the develop of novel compounds for the treatment of schizophrenia and other central nervous system disorders. The firm's drug development efforts are focused on the neurotransmitter glutamate and its critical role in the pathophysiology of schizophrenia and other disesses. It discovers, develops and markets new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. The company was founded by David A. Baker and John Mantsch in 2007 and is headquartered in Milwaukee, WI. | Health Technology |
DNASTAR, Inc.
![]() DNASTAR, Inc. Packaged SoftwareTechnology Services DNASTAR, Inc. is a bioinformatics software company that has been innovating since 1984. The private company is based in Madison, WI. The company's flagship product, Lasergene, provides a comprehensive software solution for life science researchers. | Technology Services |
- Borsa valori
- Insiders
- Sheldon Garrison